589 Phase I, Open-Label, Cohort Study of CAVATAK (Coxsackievirus A21) Given Intravenously to Stage IV Patients Bearing ICAM-1 Expressing Solid Tumours - Liauw, W.; Chern, B.; Shafren, D.R. (European Journal of Cancer, 2012)